Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD, page-147

First 147 Last

Share
Profile

Follow
itsagas

13,608 Posts.

1455

14/08/21

20:24

Post #: 55292171
Share

Originally posted by imperatore: ↑

Some food for thought:
- hold up since 2017 nothing done about it in 4 years.
- meeting with FDA unprepared as hold up always been there hanging over heads.
- apparently hold up was not mentioned during meeting even just for matter of enquire and/or if could
eventually be a problem…….very professional.
- FTD application sent and in my view without proper home work done……very professional
Mr. Diamond.
- After hinting from any corners of the world FTD was a given suddenly application withdrawn due to
hold up in dosing (remember it was there since 2017) and to be reapplied…..by when? In real time not
Diamond’s alleged deadlines.
- Latest announcement is as clear as mud (someone would say) and the Diamond instead of clarifying in
more understandable words let Dr. Gittleson to have a short sugar comment or an accountant that
instead of answering he redirect to the broker Morgan comments.
- As AKKI points out FTD has been granted to numerous bio products with less alleged “outstanding”
results but not to ATL1102……mystery.
I know that several posters think the Diamond is the best thing has happened to ANP but from the above
I really question his knowledge in scientific matters and by now since in my view time is running out also his ability to find funding. In other words it is imperative that Diamond comes out, put his face and give the share holders community some clear explanation (financial as well other application always mentioned but..?) and not the usual mmmm, hum, etc etc.
Will he do it or will keep hiding and buy time?

P.S. ITSA I don’t have any hidden agenda just ask the leader to do his job properly if he is able to otherwise move over.

Expand

Woke Imp….
you’ve never liked Diamond
but it’s the reason CG came on Board..
Understand this for the last time..
I met George and Mark in a Melbourne Pub 8 yrs ago..
They are a team.. George is a top notch Bio Scientist .. Patent lawyer…
None of us know what went on between FDA and Anp re application Fast Track…All I know it’s a work in progress

Imp:The FDA did not REJECT the Fast Track

FDA encouraged Anp to apply for FAST TRACK..

You are shitting in your own nest…

80% of long term holders on HC with credibility are happy with the ANP board ..

Morgans are happy with Anp Board

please let me know your Qualifications re Biotechs

ANP Price at posting: 17.0¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

What's causing the cost-of-living crisis, and how to navigate it

M4M

Macro, Norden set up transport solutions initiative for West Pilbara